Elevated LSD1 levels in breast cancer are associated with increased tumor aggressiveness due to its role in regulating epithelial-to-mesenchymal transition and modulating key transcription factors involved in metastasis [46,47]. This evidence concerns the gene KDM1A and neoplasm.